The diagnostic model constructed using the MS data identified exosomal proteins S100A10, UPAR, C1NH, FGR, and MASP2 as excellent predictive biomarkers of NSCLC risk. This evidence concerns the gene S100A10 and non-small cell lung carcinoma.